Healthcare & Life Sciences
Myricx Pharma
United Kingdomwww.myricxpharma.com
Myricx is a seed startup based in United Kingdom. 1 investor tracked.
activeseries-a
series-a
Stage
2018
Founded
2
Investors
About Myricx Pharma
Based in the United Kingdom, Myricx Pharma is a startup founded in 2018. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Myricx Pharma is a biotechnology company developing a novel class of cancer therapeutics based on N-myristoyltransferase (NMT) inhibition. They are building a pipeline of NMT inhibitors, including as payloads for antibody-drug conjugates (ADCs).
Explore Myricx Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.